Literature DB >> 9068310

Atopic eczema: its impact on the family and financial cost.

J C Su1, A S Kemp, G A Varigos, T M Nolan.   

Abstract

OBJECTIVE: To evaluate the impact of childhood atopic eczema on families and assess the personal financial cost of its management.
DESIGN: Cross sectional survey.
SETTING: Paediatric dermatology and paediatric diabetology outpatient clinics. PATIENTS: Parents of 48 randomly selected children with atopic eczema and 46 with insulin dependent diabetes mellitus. MAIN OUTCOME MEASURES: The impact on family score, the reported cost of relevant medical treatments, medical consultations, relevant hospitalisation, and income loss.
RESULTS: Families of children with moderate or severe atopic eczema had a significantly higher impact on family score than families of diabetic children. A conservative estimate of the annual personal financial cost of managing mild, moderate, and severe eczema was Aus$330, 818, and 1255, respectively. The financial cost to the community for the management of atopic eczema in the study groups was greater. The personal financial cost of managing eczema was greater than for asthma.
CONCLUSION: Childhood atopic eczema has a profound impact on the social, personal, emotional, and financial perspectives of families.

Entities:  

Mesh:

Year:  1997        PMID: 9068310      PMCID: PMC1717083          DOI: 10.1136/adc.76.2.159

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  Home care for ventilator-dependent children. Psychosocial impact on the family.

Authors:  R D Quint; E Chesterman; L S Crain; M Winkleby; W T Boyce
Journal:  Am J Dis Child       Date:  1990-11

2.  Grading of the severity of atopic dermatitis.

Authors:  G Rajka; T Langeland
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1989

Review 3.  Epidemiology of atopic dermatitis.

Authors:  J M Hanifin
Journal:  Monogr Allergy       Date:  1987

4.  Mothers' assessments of the impact of children with spina bifida on the family.

Authors:  M Loebig
Journal:  Matern Child Nurs J       Date:  1990

5.  Atopic dermatitis in children: who cares? Who pays?

Authors:  C S Lapidus; D F Schwarz; P J Honig
Journal:  J Am Acad Dermatol       Date:  1993-05       Impact factor: 11.527

6.  Applicability of the Impact on Family Scale for assessing families with behaviorally difficult children.

Authors:  L B Sheeber; J H Johnson
Journal:  Psychol Rep       Date:  1992-08

Review 7.  Functional performance of young children after traumatic brain injury: a 6-month follow-up study.

Authors:  W J Coster; S Haley; M J Baryza
Journal:  Am J Occup Ther       Date:  1994-03

8.  The cost of childhood asthma to Australian families.

Authors:  B G Toelle; J K Peat; C M Mellis; A J Woolcock
Journal:  Pediatr Pulmonol       Date:  1995-06
  8 in total
  54 in total

1.  Cost-effectiveness model for a specific mixture of prebiotics in The Netherlands.

Authors:  I Lenoir-Wijnkoop; W M C van Aalderen; G Boehm; D Klaassen; A B Sprikkelman; M J C Nuijten
Journal:  Eur J Health Econ       Date:  2010-12-17

2.  Environmental tobacco smoke and the risk of eczema symptoms among school children in South Africa: a cross-sectional study.

Authors:  Joyce Shirinde; Janine Wichmann; Kuku Voyi
Journal:  BMJ Open       Date:  2015-08-26       Impact factor: 2.692

Review 3.  The role of the skin microbiome in atopic dermatitis.

Authors:  Michael R Williams; Richard L Gallo
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

Review 4.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 5.  The economics of topical immunomodulators for the treatment of atopic dermatitis.

Authors:  William Abramovits; Mark Boguniewicz; Amy S Paller; Diane L Whitaker-Worth; Mary M Prendergast; Michael Tokar; Kuo B Tong
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  Comorbidity in Atopic Dermatitis.

Authors:  Eric L Simpson
Journal:  Curr Dermatol Rep       Date:  2012-03-01

7.  Hay fever, eczema, and wheeze: a nationwide UK study (ISAAC, international study of asthma and allergies in childhood).

Authors:  J B Austin; B Kaur; H R Anderson; M Burr; L S Harkins; D P Strachan; J O Warner
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

8.  Economic value of using partially hydrolysed infant formula for risk reduction of atopic dermatitis in high-risk, not exclusively breastfed infants in Singapore.

Authors:  Marc F Botteman; Abhijeet J Bhanegaonkar; Erica G Horodniceanu; Xiang Ji; Bee Wah Lee; Lynette P Shek; Hugo Ps Van Bever; Patrick Detzel
Journal:  Singapore Med J       Date:  2017-12-07       Impact factor: 1.858

9.  Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt.

Authors:  Mohamed A El-Khalawany; Hatem Hassan; Dalia Shaaban; Noha Ghonaim; Bayoumi Eassa
Journal:  Eur J Pediatr       Date:  2012-11-16       Impact factor: 3.183

10.  Mental health comorbidity in patients with atopic dermatitis.

Authors:  Pouya Yaghmaie; Caroline W Koudelka; Eric L Simpson
Journal:  J Allergy Clin Immunol       Date:  2012-12-13       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.